Supernus Pharmaceuticals reported $1.57B in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Adamas Pharmaceuticals ADMS:US 150.64M 18.6M
Aerie Pharmaceuticals AERI:US $ 355.53M 7.2M
Ani Pharmaceuticals ANIP:US $ 480.16M 16.32M
Antares Pharma ATRS:US $ 212.62M 5.84M
Aphria Inc APH:CN C$ 2.81B 5.48M
Aurora Cannabis Inc ACB:CN 2.6B 230.63M
Bristol Myers Squibb BMY:US $ 110797M 1638M
Canopy Growth Corp WEED:CN C$ 6.97B 143M
Cara Therapeutics CARA:US $ 221.45M 28.77M
Corcept Therapeutics CORT:US $ 568.48M 16.08M
Eisai 4523:JP Y 1129341M 39332M
Eli Lilly And LLY:US $ 47809M 970.7M
Endo International Ordinary Shares ENDP:US $ 9206.26M 27.91M
Gw Pharmaceuticals GWPH:US $ 934.34M 5.17M
Horizon Pharma HZNP:US $ 8207.42M 360.81M
JAZZ PHA JAZZ:US $ 13212.99M 6456.52M
Lannett LCI:US $ 683.74M 178.63M
Marinus Pharmaceuticals MRNS:US $ 124.99M 8.87M
Pacira Pharmaceuticals PCRX:US $ 1325.83M 38.28M
Perrigo Ordinary Shares PRGO:US $ 11230.3M 94.5M
Revance Therapeutics RVNC:US $ 640.88M 35.07M
Supernus Pharmaceuticals SUPN:US $ 1573.06M 65.62M
Teva Pharmaceutical Industries TEVA:US $ 49195M 191M
United Therapeutics UTHR:US $ 4844.9M 203.9M
Xeris Pharmaceuticals Inc XERS:US $ 151.5M 16.14M